Episode 96: Forging New Paths In Oncology
Tim Whitten, CEO and president of Taiho Oncology, discusses how innovative thinking—from developing new therapies to creating a podcast for employees during COVID—has played an important role in his professional journey.
19m Nov 25, 2021
19m
Episode 95: CEOs Share Their Industry Outlook
Jeff Stoll, US Life Sciences Strategy Leader at KPM, talks about some of the highlights from KPMG’s recent Global Pharma CEO Outlook report.
11m Nov 11, 2021
11m
Episode 94: Women Leading The Way
Amie Krause, Senior Vice President and Chief People Officer, and Kristin Yarema, Chief Commercial Officer, of Atara Biotherapeutics, talk about gender diversity in the c-suite and how that can benefit a company both internally and externally.
20m Oct 28, 2021
20m
Episode 93: Cultural Cues in Oncology
Michael Petroutsas, Senior Vice President and Head of GSK’s US Oncology Business Unit, talks about how his background has taught him the importance of connecting with patients on their level and how he brings that mentality to GSK.
13m Oct 14, 2021
13m
Episode 92: Digesting The GI Market
Tom McCourt, CEO of Ironwood Pharmaceuticals, talks about his 30-plus years in the gastrointestinal space, including his experiences bringing top GI medicines Prilosec, Nexium, Entocort, Zelnorm, and Linzess to market.
21m Sep 30, 2021
21m
Episode 91: A New Way to Partner With Academia
Dr. Michael Henderson, chief business officer of BridgeBio Pharma, and one of Pharm Exec’s 2021 Emerging Pharma Leaders, discusses how his company goes beyond the traditional “hand off” approach between academia and industry, and looks to partner with institutions early on to fill important voids in drug development.
19m Sep 16, 2021
19m
Episode 90: Innovating Ways to Fight Cancer
Dr. Edith Perez, Chief Medical Officer of Bolt Biotherapeutics, discusses how she approaches drug development in oncology, and what she contributes outside of work to help raise awareness for cancer.
11m Sep 02, 2021
11m
Episode 89: Cellicon Valley Outlook
Audrey Greenberg, co-founder and executive managing director of the Center for Breakthrough Medicines and Discovery Labs, discusses how cell and gene therapy has turned Philadelphia into Cellicon Valley, and how her organization is playing a role in that growth even beyond the city’s boarders.
17m Aug 19, 2021
17m
Episode 88: The Science of Starting a Biotech
Yan Chen, CEO of Elpis Biopharmaceuticals, discusses how she transformed her scientific background into launching her own biotech.
9m Aug 05, 2021
9m
Episode 87: Attacking Bladder Cancer From All Sides
Arthur Kuan, CEO of CG Oncology, talks about the present and future of bladder cancer therapies, and how he’s committed to making a difference.
11m Jul 22, 2021
11m
Behind the Creative...Inspiring Award Winning Creative with Cherie Davies
Cherie Davies, SVP, Executive Creative Director at FCB Chicago, talks about inspiring award-winning creative, especially in COVID times.
19m Jul 16, 2021
19m
Episode 86: Cancer as a Catalyst
Emma Chaffin, vice president and country head of Galapagos UK, talks about how she has dealt with her own cancer diagnosis and the effects it has had on her life and work in pharma.
14m Jul 08, 2021
14m
Episode 85: Managing the Dynamics of Oncology
Teresa Bitetti, President of the Global Oncology Business Unit at Takeda Pharmaceuticals discusses the dynamic nature of the oncology space, and how leadership style and corporate culture play an important role in managing such a business.
15m Jun 24, 2021
15m
Episode 84: Vaccines Beyond COVID
Judy Stewart, head of US vaccines at GSK, talks about the effects of people missing their recommended vaccinations during the pandemic and the importance of delivering a message of value for vaccines.
15m Jun 10, 2021
15m
Behind the Creative...Inspiring Award Winning Creative with Kathy Delaney
Tina and Kathy Delaney, CCO of Publicis Health/Saatchi Wellness, chat about creative inspiration, trends and surreal career moments in this episode of Behind the Creative.
22m Jun 10, 2021
22m
Episode 83: The Strength of Veterans in Pharma
Mike Starich, CEO of Orion Talent, and Dr. Armand Balboni, CEO of Appili Therapeutics, discuss how veterans have specific skills and qualities that can set them up for success in pharma, and what the industry can do to uncover their potential.
21m May 27, 2021
21m
Behind the Creative: Creative Impact on Brand Success
Darrell Wakefield, Franchise Head, Solid Tumor, Sanofi Genzyme, talks creative impact on brand success.
16m May 25, 2021
16m
Announcing Our 2021 Emerging Pharma Leaders
Since 2008, Pharmaceutical Executive has recognized a class of biopharma professionals to receive the title Emerging Pharma Leader. This year, along with their profiles in our May issue, our editorial team presents a webcast featuring the winners and their up-and-coming perspectives on a range of industry topics. Get a full list of our #2021EPL and read their profiles here:https://www.pharmexe...
34m May 21, 2021
34m
Episode 82: Integrating Sustainability Into Biopharma Strategy
Sandor Schoichet, an independent advisor, and director of Meridian Management Consultants based in San Francisco, and Pharm Exec’s Sustainability columnist, and his co-collaborator, Thomas Scheiwiller, an independent advisor and board member based in Zurich, discuss many of the topics we touch on today in regard to biopharma’s approach to integrating environmental, social, and governance, or ES...
20m May 13, 2021
20m
Behind the Creative: Inspiring Award-Winning Creative
Shaheed Peera, President, Founder and CEO of The Creative Floor Awards, London, and Global Creative Lead for Reckitt Benckiser ECom, talks about inspiring award-winning creative, reflects on his time as President on Cannes, and provides some insight on his award show The Creative Floor as well as a few tips about the inaugural PharmExec APEX Awards Submit your PE APEX nominations here: https:/...
40m May 03, 2021
40m
Episode 81: Cancer Research Amid COVID
Dr. Michele Cleary, CEO of the Mark Foundation for Cancer Research, discusses how the foundation has navigated COVID to help keep critical cancer research going throughout the pandemic.
17m Apr 29, 2021
17m
Episode 80: Rugby Rules in Pharma
John Furey, CEO of Imvax and an Editorial Advisory Board member for Pharm Exec, discusses some leadership principles he learned while playing rugby as a young man in Ireland, and how those tenets can translate to the C-suite.
15m Apr 15, 2021
15m
Episode 79: Managing Quarantine Remotely
Uche Iloeje, Vice President medical affairs Mirdametenib at SpringWorks Therapeutics, shares his experience after he became stranded in Nigeria for five months and the valuable leadership lessons he learned.
18m Apr 01, 2021
18m
Episode 78: The Digital Denouement of COVID
Paul Shawah, Executive Vice President of Strategy at Veeva Systems, looks back at the past year of the pandemic to see the digital transformation of pharma’s interaction with healthcare professionals.
14m Mar 18, 2021
14m
Episode 77: The Effects of AI on IP
Kevin Buckley, founder of Torrey Pines Law Group, and Neil Thompson, a patent agent with the firm, discuss IP strategy as it relates to pharma and artificial intelligence.
14m Mar 04, 2021
14m
Episode 76: Repatriating Pharma
Joel Marcus, founder and executive chairman of Alexandria Real Estate Equities, and founder and CEO of Alexandria Venture Investments, discusses the drive to bring pharma manufacturing back to a company’s home country and the issues involved in doing so.
15m Feb 18, 2021
15m
Episode 75: Protecting Pharma Through Cybersecurity
Scott Nawrocki, managing director of digital investigations and cyber defense at Nardello & Co., discusses cybersecurity in pharma, including topics from prevention to crisis management.
32m Feb 04, 2021
32m
Episode 74: 2021 Industry Outlook
Editorial Director, Lisa Henderson; European and online editor, Julian Upton; Senior Editor, Elaine Quilici ;and Assistant Editors of Pharmaceutical Executive, Miranda Schmalfuhs and Andy Studna, discuss some exciting industry trends for 2021, which they recently wrote for the January issue.
25m Jan 21, 2021
25m
Episode 73: Biotech’s IPO Steamroll
Gregg Beloff, co-founder of Danforth Advisors, discusses the banner year biotech IPOs had in 2020, the drive behind that boom, and what the future of industry IPOs might look like
11m Jan 07, 2021
11m
Episode 72: Trying to Outpace Rare Disease
Rich Horgan, founder and president of Cure Rare Disease(CRD), discusses how he sprang into action when his brother was diagnosed with Duchenne muscular dystrophy, by starting a nonprofit biotech to help find a cure.
22m Dec 24, 2020
22m
Episode 71: Connecting With NPs and PAs
Sacha Ward, chief client officer of Point of Care Network, discusses how COVID has affected the roles of nurse practitioners and physician assistants, and why marketing managers should take a moment to understand this growing group of health care influencers.
13m Dec 10, 2020
13m
Episode 70: Keeping Pharma Informed
Krystle Buntemeyer, president of SCORR Marketing, and Bharat Mehta, co-founder of PharmaCompass, discuss a new, free online tool called Pipeline Prospector, which they recently launched in collaboration. The tool aims to provide pharma executives with industry data, including deal and pipeline information, to help them make more informed decisions.
13m Nov 26, 2020
13m
Episode 69: Fighting Influenza During COVID
Dr. Gregg Sylvester, chief medical officer of Seqirus, discusses the importance of vaccinating against the seasonal flu amid the COVID pandemic, and how the two viruses should be considered in light of each other.
9m Nov 12, 2020
9m
Episode 68: Rocking Garage Biotech
Panna Sharma, CEO of Lantern Pharma, discusses garage biotech, what he’s learned from the culture, and how it might help transform certain areas of pharma, including innovation and pricing.
23m Oct 29, 2020
23m
Episode 67: Succeeding Through Adversity
Sanjeev Luther, president and CEO of Rafael Pharmaceuticals, discusses how he managed to turn around a company on the brink of bankruptcy and advance clinical trials for its lead cancer drug through COVID-19.
11m Oct 15, 2020
11m
Episode 66: New Approach to Antithrombotics
Dr. Neil Hayward, CEO and founder of eXlthera, is here to discuss his company, which is developing Factor XI inhibitor antithrombotics that are attacking blood clots from a new angle and are giving patients new hope.
18m Oct 01, 2020
18m
Episode 65: Creating a Path for Innovation
George Baxter, CEO of Edinburgh Innovations, is here to discuss the company's commercialization model, and how his group is bringing innovation to market in Scotland.
15m Sep 17, 2020
15m
Episode 64: The Complexities of Managing ADHD
Jack Khattar, president and CEO of Supernus Pharmaceuticals, talks about his experience bringing ADHD drugs to market in a challenging environment.
16m Sep 03, 2020
16m
Episode 63: Three Simple Principles to Improve Leadership
Eric Turbiville, author of the recently published book “The Perfect Leadership Triad: How Top Executives Maximize Productivity through People, Coaching, and Performance," a 25-year pharma veteran, credentialed executive coach, and director of mentoring for the Southwest region of the Healthcare Businesswomen’s Association says there are three leadership principles can help executives through tu...
17m Aug 20, 2020
17m
Episode 62: The Future of Pharma’s Supply Chain
Kurt Orlofski, CEO of Pharmaceutical Associates Inc., discusses what the pharmaceutical supply chain might look like post COVID-19, and how companies can prepare for that.
19m Aug 06, 2020
19m
Episode 61: Preparing for Virtual High-Stakes Meetings
Jim and Cindy DiBiasi, co-founders of 3D Communications, talk about how to prepare for virtual high-level meetings, such as important regulatory presentations and keynote addresses, in the wake of COVID-19.
17m Jul 23, 2020
17m
Episode 60: Leading With Compassion
Tim Walbert, CEO of Horizon Therapeutics, shares his unique perspective on managing the Chicago location of the company through COVID-19, in light of the fact that he himself is immunocompromised.
14m Jul 09, 2020
14m
Episode 59: Using Tau to Target Alzheimer’s
Janice Kranz, co-founder of Eikonizo Therapeutics, bring us up to date on how targeting tau to fight Alzheimer’s and other neurodegenerative diseases is making waves in the CNS space.
15m Jun 25, 2020
15m
Episode 58: Understanding FDA’s Gene Therapy Guidelines
Dr. Jonathan Gertler, CEO of Back Bay Life Science Advisors, and Dr. Stephan Gauldie, Managing Director of Back Bay, talk about the new guidelines set forth by FDA in regard to gene therapy, and what those new parameters mean for pharma and biotech.
19m Jun 11, 2020
19m
Episode 57: Planning for Pharma’s New Normal
Pratap Khedkar, managing principal of ZS Associates, talks about pharma’s scenario planning amid COVID-19 as it looks to settle into a new normal.
18m May 28, 2020
18m
Episode 56: Killing Cancer Through Direct Injection
Lew Bender, founder of Intensity Therapeutics and the inventor of Intensity’s DfuseRx platform technology, discusses the technology that allows the company’s therapeutic products to be injected directly into solid tumors, this innovative process successfully kills tumors and activates an immune response to shut down cancer cells throughout the body.
17m May 14, 2020
17m
Episode 55: Developing a Maternal RSV Vaccine
Kathrin Jansen, Senior Vice President and Head of Vaccine Research and Development at Pfizer, talks about the challenges of creating a new maternal vaccine for respiratory syncytial virus, also known as RSV, currently being administered to pregnant women in trials, in the hopes of protecting their infants.
18m Apr 30, 2020
18m
Episode 54: Taking Advantage of Digital Marketing
Chris Paquette, DeepIntent co-founder and CEO, talks about the evolution of digital marketing in pharma, specifically, how to approach data and technology usage in a privacy-first world.
15m Apr 15, 2020
15m
Episode 53: Fabulous Pharma Females
Barbara Ryan, founder of Barbara Ryan Advisors, a member of PharmExec’s editorial advisory board, and the founder of Fabulous Pharma Females discusses the strong community she’s built providing women the opportunity to connect with each other and reinforce their shared commitment to one another.
17m Apr 02, 2020
17m
Episode 52: Cannabinoids
Yuval Cohen, CEO of Corbus Pharmaceuticals, talks about cannabinoids, the differences between natural and synthetic products, and how biotechs and pharma are using them to treat disease today.
16m Mar 19, 2020
16m